The scientific use of basal insulin is of great help to individuals and the government. However, there are few studies to investigate the real world use, effect, safety and influence factors of basal insulin in China. This study is to evaluate the use of first basal insulin in China patients with type 2 diabetes with inadequate glycemic control on oral antidiabetic agents (OADs) from the naturalistic clinical practice.
This is a 6-month multicentre, observational, prospective, registry study. About 200 hospitals from different parts of China will take part in this study, and about 20,000 patients with type 2 diabetes mellitus (T2DM) who are inadequately controlled with OADs and willing to accept basal insulin (BI) treatment will be consecutively enrolled during a 12 months period. The study participants will include at baseline (0 month), 3 month and end point (6 month) to collect the study information. The project will probably last for about 18 months.
Study Type
OBSERVATIONAL
Enrollment
19,894
Haidian hospital
Beijing, Beijing Municipality, China
Peking University People's Hospital
Beijing, Beijing Municipality, China
To Assess the Change in HbA1c During the 6 Months Follow-up.
• Change of HbA1c from baseline to the end-point (6 month).
Time frame: Baseline and 6 months
the Change of Hypoglycemia During Follow-up.
•The rate of hypoglycemia at baseline, 3 months (visit 2) and 6 months (visit 3)
Time frame: baseline and 6 months
the FPG Change From Visit 1 to Visit 3
the FPG change = the FPG level at visit 1- the FPG level at visit 3
Time frame: baseline and 6 months
the FPG Control Rate at Visit 3
the percentage of patients who had the FPG level \<7.0 mmol/L at visit 3
Time frame: 6 months
Overall Weight Gain From Visit 1 to Visit 3
the weight gain= the mean weight at visit1 - the mean weight at visit 3
Time frame: baseline and 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.